Chemoradiation and the role of adjuvant chemotherapy in lymph nodal-metastatic cervical cancer

Nasir Ali, Azmina Tajdin, Valimohammad, Ahmed Nadeem Abbasi, Muhammad Atif Mansha, Asim Hafiz, Bilal Mazhar Qureshi

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Purpose To report the long-term outcome in lymph nodal-metastatic cervical squamous cell cancer after chemoradiation followed by adjuvant chemotherapy. Patients and Methods Between 2010 and 2013, five patients were diagnosed with advanced cervical cancer with clinically involved para-aortic lymph nodes (ie, International Federation of Gynecology and Obstetrics stage IVB). These patients were treated with concurrent chemoradiation therapy followed by adjuvant chemotherapy. Concurrent chemoradiation consisted of cisplatin given once per week concomitantly with extended-field radiation therapy followed by high-dose-rate brachytherapy. Adjuvant chemotherapy comprised four courses of carboplatin and paclitaxel given every three weeks. The primary outcomes were local and distant failures. Results None of the patients had local recurrence or distal failure after a minimum follow-up time of 3 years. Conclusion Adjuvant chemotherapy after chemoradiation has a probable role in the management of lymph nodal-metastatic cervical cancer.

Original languageEnglish
Article number009852
JournalJournal of global oncology
Issue number4
Publication statusPublished - 2018


Dive into the research topics of 'Chemoradiation and the role of adjuvant chemotherapy in lymph nodal-metastatic cervical cancer'. Together they form a unique fingerprint.

Cite this